Valsartan slows the progression of diabetic nephropathy indb/dbmice via a reduction in podocyte injury, and renal oxidative stress and inflammation
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Valsartan slows the progression of diabetic nephropathy indb/dbmice via a reduction in podocyte injury, and renal oxidative stress and inflammation
Authors
Keywords
-
Journal
CLINICAL SCIENCE
Volume 126, Issue 10, Pages 707-720
Publisher
Portland Press Ltd.
Online
2013-11-07
DOI
10.1042/cs20130223
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Nox4 Is a Protective Reactive Oxygen Species Generating Vascular NADPH Oxidase
- (2012) Katrin Schröder et al. CIRCULATION RESEARCH
- Renoprotective effects of a novel Nox1/4 inhibitor in a mouse model of Type 2 diabetes
- (2012) Mona Sedeek et al. CLINICAL SCIENCE
- Inflammation and the pathogenesis of diabetic nephropathy
- (2012) Jun Wada et al. CLINICAL SCIENCE
- Targeting reduction of proteinuria in glomerulonephritis: Maximizing the antifibrotic effect of valsartan by protecting podocytes
- (2012) Chunyan Gu et al. JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM
- Role of endothelial Nox2 NADPH oxidase in angiotensin II-induced hypertension and vasomotor dysfunction
- (2011) Colin E. Murdoch et al. BASIC RESEARCH IN CARDIOLOGY
- Angiotensin II induces nephrin dephosphorylation and podocyte injury: Role of caveolin-1
- (2011) Zhilong Ren et al. CELLULAR SIGNALLING
- Suppressive Effects of Valsartan on Microalbuminuria and CRP in Patients with Metabolic Syndrome (Val-Mets)
- (2011) Tetsuro Shishido et al. CLINICAL AND EXPERIMENTAL HYPERTENSION
- Angiotensin II-dependent persistent podocyte loss from destabilized glomeruli causes progression of end stage kidney disease
- (2011) Akihiro Fukuda et al. KIDNEY INTERNATIONAL
- Effects and mechanisms of angiotensin II receptor blockade with telmisartan in a normotensive model of mesangioproliferative nephritis
- (2011) Luigi Villa et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- ANG II promotes autophagy in podocytes
- (2010) Anju Yadav et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- NOX2 is the primary source of angiotensin II-induced superoxide in the macula densa
- (2010) Yiling Fu et al. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- Angiotensin blockade in diabetic patients decreases insulin resistance-associated low-grade inflammation
- (2010) Maria G. Pavlatou et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Normalizing NADPH Oxidase Contributes to Attenuating Diabetic Nephropathy by the Dual Endothelin Receptor Antagonist CPU0213 in Rats
- (2008) Ming Xu et al. AMERICAN JOURNAL OF NEPHROLOGY
- Oxidative Stress as a Major Culprit in Kidney Disease in Diabetes
- (2008) J. M. Forbes et al. DIABETES
- Mechanisms of angiotensin II signaling on cytoskeleton of podocytes
- (2008) Hsiang-Hao Hsu et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- A PAI-1 Mutant, PAI-1R, Slows Progression of Diabetic Nephropathy
- (2008) Y. Huang et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Comparison of Dual RAAS Blockade and Higher-Dose RAAS Inhibition on Nephropathy Progression
- (2008) George L. Bakris et al. POSTGRADUATE MEDICINE
- Angiotensin II-induced skeletal muscle insulin resistance mediated by NF-κB activation via NADPH oxidase
- (2007) Yongzhong Wei et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started